Improving Imaging Diagnosis of Persistent Nodal Metastases after Definitive Therapy for Oropharyngeal Carcinoma: Specific Signs for CT and Best Performance of Combined Criteria

REFERENCES

1. 1.↵
   1. Mendenhall WM,
   2. Morris CG,
   3. Amdur RJ,
   4. et al

   . Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol 2006;29:290–97

   CrossRefPubMed
2. 2.↵
   1. Mendenhall WM,
   2. Morris CG,
   3. Amdur RJ,
   4. et al

   . Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol 2006;29:32–39

   CrossRefPubMed
3. 3.↵
   1. Boyd TS,
   2. Harari PM,
   3. Tannehill SP,
   4. et al

   . Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 1998;20:132–37

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Clavel S,
   2. Charron MP,
   3. Belair M,
   4. et al

   . The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012;82:567–73

   CrossRefPubMed
5. 5.↵
   1. Doweck I,
   2. Robbins KT,
   3. Mendenhall WM,
   4. et al

   . Neck level-specific nodal metastases in oropharyngeal cancer: is there a role for selective neck dissection after definitive radiation therapy? Head Neck 2003;25:960–67

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Liauw SL,
   2. Mancuso AA,
   3. Amdur RJ,
   4. et al

   . Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 2006;24:1421–27

   Abstract/FREE Full Text
7. 7.↵
   1. Narayan K,
   2. Crane CH,
   3. Kleid S,
   4. et al

   . Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 1999;21:606–13

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Simon C,
   2. Goepfert H,
   3. Rosenthal DI,
   4. et al

   . Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol 2006;263:313–38

   CrossRefPubMed
9. 9.↵
   1. Dahlstrom KR,
   2. Li G,
   3. Tortolero-Luna G,
   4. et al

   . Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck 2011;33:847–55

   CrossRefPubMed
10. 10.↵
    1. Ang KK,
    2. Harris J,
    3. Wheeler R,
    4. et al

    . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35

    CrossRefPubMedWeb of Science
11. 11.↵
    1. D'Souza G,
    2. Kreimer AR,
    3. Viscidi R,
    4. et al

    . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944–56

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Greven KM,
    2. Williams DW 3rd.,
    3. Browne JD,
    4. et al

    . Radiographic complete response on post treatment CT imaging eliminates the need for adjuvant neck dissection after treatment for node positive head and neck cancer. Am J Clin Oncol 2008;31:169–72

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Clayman GL,
    2. Johnson CJ 2nd.,
    3. Morrison W,
    4. et al

    . The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001;127:135–39

    PubMedWeb of Science
14. 14.↵
    1. Yeung AR,
    2. Liauw SL,
    3. Amdur RJ,
    4. et al

    . Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection? Cancer 2008;112:1076–82

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Ojiri H,
    2. Mendenhall WM,
    3. Stringer SP,
    4. et al

    . Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002;52:420–28

    CrossRefPubMed
16. 16.↵
    1. Eisenhauer EA,
    2. Therasse P,
    3. Bogaerts J,
    4. et al

    . New response evaluation criteria in solid tumours: revised RECIST guideline (Version 1.1). Eur J Cancer 2009;45:228–47

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Ojiri H,
    2. Mancuso AA,
    3. Mendenhall WM,
    4. et al

    . Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. AJNR Am J Neuroradiol 2002;23:1627–31

    Abstract/FREE Full Text
18. 18.↵
    1. Goldenberg D,
    2. Begum S,
    3. Westra WH,
    4. et al

    . Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008;30:898–903

    CrossRefPubMed
19. 19.↵
    1. Agbahiwe HC,
    2. Marur S,
    3. Forastiere AA,
    4. et al

    . Lymph node density and response to induction TPF in patients with HPV-related head and neck cancer. In: Proceedings of the Annual Meeting of the American Society of Clinical Oncology, Chicago, Illinois. June 4–8, 2011
20. 20.↵
    1. Moeller BJ,
    2. Rana V,
    3. Cannon BA,
    4. et al

    . Prospective imaging assessment of mortality risk after head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:667–74

    CrossRefPubMed
21. 21.↵
    1. Enomoto K,
    2. Inohara H,
    3. Higuchi I,
    4. et al

    . Prognostic value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy. Mol Imaging Biol 2008;10:224–29

    CrossRefPubMed
22. 22.↵
    1. Yom SS,
    2. Garden AS,
    3. Staerkel GA,
    4. et al

    . Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer. AJNR Am J Neuroradiol 2011;32:1532–58

    Abstract/FREE Full Text
23. 23.↵
    1. Greven KM,
    2. Williams DW 3rd.,
    3. McGuirt WF Sr.,
    4. et al

    . Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 2001;23:942–46

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Gupta T,
    2. Master Z,
    3. Kannan S,
    4. et al

    . Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011;38:2083–95

    CrossRefPubMed
25. 25.↵
    1. Wong RJ,
    2. Lin DT,
    3. Schoder H,
    4. et al

    . Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199–208

    Abstract/FREE Full Text
26. 26.↵
    1. Rogers JW,
    2. Greven KM,
    3. McGuirt WF,
    4. et al

    . Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 2004;58:694–97

    CrossRefPubMedWeb of Science